Auszug
Herzchirurgische Eingriffe gehören zu den häufigsten Operationen weltweit. Die Anzahl der Eingriffe ist bis vor wenigen Jahren kontinuierlich gestiegen. Im Jahr 2003 wurden in Deutschland knapp 95.000 Eingriffe mir extrakorporaler Zirkulation (EKZ) durchgeführt. Die Indikationen für herzchirurgische Eingriffe schließen myokardiale Ischämien, Herzvitien, Herzinsuffizienz, kongenitale Fehlbildungen und Arrhythmien mit ein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aasbo J, Lawrence A, Krishnan K et al. (2005) Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after car-diac surgery: A meta analysis. Ann Intern Med 143:327–336
ACTIVE Writing Group (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomized controlled trial. Lancet 367:1903–19012
André AC, DelRossi A (2005) Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 33(9): 2082–2093
Bent P, Tan HK, Bellomo R et al. (2001) Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann ThoracSurg 71:832–837
Berghevan den G, Wouters P, Weekers Fetal. (2001) Intensiv insulin therapie in critically ill patients. N Engl J Med. 8;345(19): 1359–13567
Brix-Christensen V (2001) The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. ActaAnaesthesiol Scand 45:671–679
Bucerius J, Gummert JF, Borger MA et al. (2003) Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75:472–478
Cheng DC, Bainbridge D, Martin JE, et al. (2005) Does off-pump coronary artery bypass reduce mortality, morbidity and resource utilization when compared to conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102: 188–203
Cox C, Ascione R, Cohen A et al. (2000) Effect of cardiopulmonary bypass on pulmonary gas exchange: A prospective randomized study. Ann Thorac Surg 69:140–145
Devbhandari M, Duncan A, Grayson A et al. (2006) Affect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass grafting: a multi-centre study. Eur J Cariothorac Surg 29:964–970
Dueck M, Klimek M, Appenrodt S, Weigand C, Boerner U (2005) Trend but not individual values of central venous oxygen saturation agree with mixed venous oxygen saturation during varying hemodynamic conditions. Anesth. 103:249–257
Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock. A prospektive, randomized, controlled study. Circulation 107:2313–2319
Feneck R, Sherry KM, Withington PS et al. (2001) Comparison of hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 3:206–215
Follath F, Cleland JG, Just H et al. (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (The LIDO study) Lancet 360:196–202
Fowler VG, O’Brien SM, Muhlbaier LH et al. (2005) Clinical predictors of major infections after cardiac surgery. Circulation 112;(Suppl I) I: 358–365
Goepfert M, Reuter D, Akyol D et al. (2006) Goal directed fluid ma-nagement reduces vasopressor and catecholamine use in cardiac surgery patients. Intensive Care Med 8:96–103
Henry DA, Moxey AJ, Carless PA et al. (2001) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev CD001886
Hessel EA (2004) Abdominal organ injury after cardiac surgery. Sem Cardioth Vasc Anesth 8;3:243–263
Jakob SM, Ruokonen E, Takala J (2002) Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18:8–13
James K, Militello M, Gus B, Wilkhoff B (2006) Biventricular pacing for heart failure patients on inotropic support. Tex Heart Inst J 33: 19–22
Kaul TK, Fields BL (2000) Postoperative acute refractory right ventricular failure: Incidence, pathogenesis, management and prognosis. Cardiovasc Surg 8:1–9
Kilger E, Weis F, Briegel J et al. (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31:1068–1074
Koch CG, Li L, Duncan A, Mihaljevic Tet al. (2006) Morbidity and Mortality riskassociated with red blood cell and blood-componenttransfusion in isolated coronary artery bypass grafting. Crit Care Med 34,6
Lahtinen, J, Biancari F, Salmela et al. (2004) Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 77:1241–1244
Lazar H (2004) Role of statin therapy in the coronary bypass patient. Ann Thorac Surg 78:730–740
Levin RL, Degrange M, Bruno G et al. (2004) Methylene Blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77:496–499
Mangano DT (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309–1317
Mangano DT, Tudor J, Diezel C (2006) The risk associated with aproti-nin in cardiac surgery. N Engl J Med 354:353–365
Mathew J, Fontes M, Tudor I, Ramsay J et al. (2004) A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291(14): 1720–1729
Meier-Hellmann A, Reinhart K, Bredle DL et al. (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med;25:399–404
Möhnle P, Kilger E (2002) Kreislaufunterstützung durch die intraaortale Gegenpulsation. Anästhesist 51:687–701
Pieske B (2002) Levosimendan in regional myocardial ischämie Car-diovasc Drugs Ther 16:379–381
Polonen P, Ruokonen E, Hippelainen M et al. (2000) A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90:1052–1059
Raja S, Rayen B. (2006) Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 81:1536–1546
Royster RL, Butterworth JF, Prielipp RC et al. (1993) Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Analg;77:662–672
Schelling G, Roozendaal B, Krauseneck T et al. (2006) Efficacy of hy-drocortisone in preventing posttraumatic stress sisorder following critical illness and major surgery. Ann N Y Acad Sci 1071:46–53
Shore-Lesserson L (2005) Evidence based coagulation monitors: Heparin monitoring, thromboelastography and plateled function. Semin Cardiothorac Vasc Anesth Mar 9(1):41
Stafford-Smith M (2005) Evidence-Based renal protection in cardiac surgery. Semin Cardiothorac Vasc Anesth Mar 9(1): 65–76
Toraman F, Karabulut EH, Alhan HC, etal. (2001) Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Torac Surg 72:1256–1261
Totaro RJ, Raper RF (1997) Epinephrine-indused lactateacidosisfollowing cardiopulmonary bypass. Crit Care Med 25:1693–1699
Van Belleghem Y, Caes F, Maene L et al. (2003) Off-pump coronary surgery: surgical strategy for the high-risk patient. Cardiovasc Surg 11:75–79
Weisse U, Isgro F, Werling C, Saggan W (2002) Impact of atrio-biventricular pacing to poor left-ventricular function after CABG. Thorac Cardiovasc Surg 50(3): 131–135
Westerdahl E, Lindmark B, Bryngelsson I, Tenling A (2003) Pulmonary function 4 month after coronary artery bypass graft surgery. Respir med 97:317–322
Wright EM, Sherry KM. (1991) Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery. Br J Anaesth 67:585–590
Zimmer J, Pezullo J, Choucair W et al. (2003) Metaanalysis of antiarrhythmic therapie in the prevention of postoperativ AF and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 91: 1137–1141
Zwissler B (2000) Das akute Rechtsherzversagen. Ätiologie, Pathophysiologie, Diagnostik, Therapie. Anästhesist 49:788–808
Deutsche Gesellschaft für Thorax-, Herz-und Gefässchirurgie (DGTHG) Stellungnahme zum Risiko bei der Verwendung von Aprotinin in der Herzchirurgie.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Nassau, K., Kasel, K., Kilger, E., Zwiβler, B. (2008). Intensivtherapie nach herzchirurgischem Eingriff. In: Burchardi, H., Larsen, R., Kuhlen, R., Jauch, KW., Schölmerich, J. (eds) Die Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72296-0_75
Download citation
DOI: https://doi.org/10.1007/978-3-540-72296-0_75
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72295-3
Online ISBN: 978-3-540-72296-0
eBook Packages: Medicine (German Language)